Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter

Endocrinology

Volumn 138, Issue 4, 1997, Pages 1604-1611

  Tozzo, Effie ^a,b   Gnudi, Luigi ^a   Kahn, Barbara B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Ergo Science Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORT; HYPOINSULINEMIA; INSULIN RESISTANCE; LIPOLYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STREPTOZOCIN DIABETES; TRANSGENE; TRANSLATION REGULATION;

EID: 0030988551     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.4.5043     Document Type: Article

References (43)

1. Yki-Jarvinen H, Sahlin K, Ren JM, Koivisto VA 1990 Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes 39:157-167
2. Hother-Nielsen O, Schmitz O, Bak J, Beck-Nielsen H 1987 Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes. Diabetologia 30:834-840
3. Olefsky JM, Kolterman OG, Scarlett JA 1982 Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol 243:E15-E30
4. Hidaka H, Nagulesparan M, Klimes 1982 Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetes. J Clin Endocrinol Metab 54:217-222
5. Shepherd P, Kahn B 1993 Cellular defects in glucose transport: lessons from animal models and implications for human insulin resistance. In: Moller D (ed) Insulin Resistance. John Wiley and Sons, Ltd., Sussex, UK, pp 253-281
6. Kahn BB, Charron MJ, Lodish HF, Cushman SW, Flier JS 1489 Differential regulation of two glucose transporters in adipose cells from diabetic and insulin treated diabetic rats. J Clin Invest 84:404-411
7. Garvey WT, Maianu L, Huecksteadt TP, Birnbaum MJ, Molina JM, Ciaraldi TP 1991 Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J Clin Invest 87:1072-1081
8. Olson A, Liu ML, Moye-Rowley WS, Buse JB, Bell GI, Pessin JE 1993 Hormonal/metabolic regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice. J Biol Chem 268:9839-9846
9. Abel ED, Shepherd PR, Kahn BB 1996 Glucose transporters and pathophysiologic states. In: LeRoith DR, Olefsky JM, Taylor SI (eds) Diabetes Mellitus: A Fundamental and Clinical Text. JP Lippincott Co., Philadelphia, pp 530-543
10. Richardson JM, Balon TW, Treadway JL, Pessin JE 1991 Differential regulation of glucose transporter activity and expression in red and white skeletal muscle. J Biol Chem 266:12690-12694
11. Youn J, Kim J, Buchanan T 1994 Time courses of changes in hepatic and skeletal muscle insulin action and Glut4 protein in skeletal muscle after STZ injection. Diabetes 43:564-571
12. Ikemoto S, Thompson KS, Takahashi M, Itakura H, Lane MD, Ezaki O 1995 High fat diet-induced hyperglycemia: prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice. Proc Natl Acad Sci USA 92:3096-3099
13. Gibbs EM, Stock JL, McCoid SC, Stukenbrok HA, Pessin JE, Stevenson RW, Milici AJ, McNeish JD 1995 Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (Glut4). J Clin Invest 95:1512-1518
14. Deems R, Evans J, Deacon R, Honer C, Chu D, Burki K, Fillers W, Cohen D, Young DA 1994 Expression of human GLUT4 in mice results in increased insulin action. Diabetologia 37:1097-1104
15. Ren J, Marshall B, Mueckler M, McCaleb M, Amatruda J, Shulman G 1995 Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J Clin Invest 95:429-432
16. Treadway J, Hargrove M, Nardone N, McPherson R, Russo J, Milici A, Stukenbrok H, Gibbs E, Stevenson R, Pessin J 1994 Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT-4 gene. J Biol Chem 269:29956-29961
17. Leturque A, Loizeau M, Vaulont S, Salminen M, Girard J 1996 Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes 45:23-27
18. Tsao TS, Burcelin R, Katz EB, Huang L, Charron MJ 1996 Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45:28-36
19. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB 1993 Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 268:22243-22246
20. Ross SR, Graves RA, Greenstein A, Platt KA, Shyu H, Mellovitz B, Spiegelman BM 1990 A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc Natl Acad Sci USA 87:9590-9594
21. Buse JB, Yasuda K, Lay TP, Seo TS, Karam JH, Seino S, Bell GI 1992 Human GLUT4 muscle/fat glucose transporter gene: sequence, promoter characterization and genetic variations. Diabetes 41:1436-1446
22. Tozzo E, Shepherd PR, Gnudi L, Kahn BB 1995 Transgenic GLUT4 overexpression in fat enhances glucose metabolism: preferential effect on fatty acid synthesis. Am J Physiol 268:E956-E964
23. Kashiwagi K, Antonio-Verso M, Andrews J, Vasquez B, Reaven G, Foley JE 1983 In vitro insulin resistance of human adipocytes isolated from subjects with non insulin dependent mellitus. J Clin Invest 72:1246-1254
24. Foley JE 1986 Clarke WL, Larner J, Pohl SL (eds) Methods in Diabetes Research. J Wiley and Sons Inc., New York, pp 211-232
25. Honnor RC, Dhillon GS, Londos C 1985 cAMP-dependent protein kinase and lipolysis in rat adipocytes. II. Definition of steady-state relationship with lipolytic and antilipolytic modulators. J Biol Chem 260:15130-15138
26. Londos C, Honnor RC, Dhillon GS 1985 cAMP-dependent protein kinase and lipolysis in rat adipocytes. J Biol Chem 260:15139-15145
27. Bradley DC, Kaslow HR 1989 Radiometric assays for glycerol, glucose and glycogen. Anal Chem 180:11-16
28. Pedersen O, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, Kahn BB 1990 Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39:865-870
29. Hirsch J, Gallian E 1968 Method for the determination of adipose cell size in man and animals. J Lipid Res 9:110-119
30. Cushman SW, Salans LB 1978 Determinations of adipose cell size and number in suspensions of isolated rat and human adipose cells. J Lipid Res 19:269-273
31. Wallberg-Henriksson H, Zetan N, Henriksson J 1987 Reversibility of decreased insulin-stimulated glucose transport capacity in diabetic muscle with in vitro incubation. J Biol Chem 262:7665-7671
32. Marin P, Rebuffe-Scrive M, Smith U, Bjorntorp P 1987 Glucose uptake in human adipose tissue. Metabolism 36:1154-1160
33. Digirolamo M, Newby FD, Lovejoy J 1992 Lactate production in adipose tissue: a regulated function with extra-adipose implications. FASEB J 6:2405-2412
34. DeFronzo RA, Jacto E, Jequier E, Maeder E, Wahren J, Felber JP 1981 The effect of insulin on the disposal of intravenous glucose. Diabetes 30:1000-1007
35. Gnudi L, Tozzo E, Shepherd PR, Bliss JL, Kahn BB 1995 High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance. Endocrinology 135:995-1002
36. Cheatham B, Kahn CR 1995 Insulin action and the insulin signaling network. Endocr Rev 16:117-142
37. Okamolo M, White MF, Maron R, Kahn CR 1986 Autophosphorylation and kinase activity of insulin receptor in diabetic rats. Am J Physiol 251:E542-E550
38. Burant CF, Treutelaar MK, Buse MG 1986 Diabetes-induced functional and structural changes in insulin receptors from rat skeletal muscle. J Clin Invest 77:260-270
39. Nishimura H, Kuzuya H, Okamoto M, Yamada K, Kosaki A, Kakehi T, Inoue G, Kono S, Imura H 1989 Postreceptor defect in insulin action in streptozotocin induced diabetic rats. Am J Physiol 256:E624-E630
40. Giorgino F, Chen J, Smith RJ 1992 Changes in tyrosine phosphorylation of insulin receptors and a 170,000 molecular weight nonreceptor protein in vivo in skeletal muscle of streptozotocin induced diabetic rates: effects of insulin and glucose. Endocrinology 130:1433-1444
41. Folli F, Saad MJA, Backer JM, Kahn CR 1993 Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistance and insulin-deficient diabetes mellitus. J Clin Invest 92:1787-1794
42. Kahn BB, Cushman SW 1987 Mechanisms for markedly hyperresponsive insulin-stimulated glucose transport activity in adipose cells from insulin-treated streptozotocin diabetic rats: evidence for increased glucose transporter intrinsic activity. J Biol Chem 262:5118-5124
43. Liu ML, Gibbs EM, McCoid SC, Milici AJ, Stukenbrok HA, McPherson RK, Treadway JL, Pessin JE 1993 Transgenic mice expressing the human GLUT4/ muscle-fat facilitative glucose transporter protein exhibit efficient glycemic control. Proc Natl Acad Sci USA 90:11346-11350